Financials
- Market Capitalization 315.35 M
- Employee 158
- Founded 2017
- CEO N/A
- Website www.cabalettabio.com
- Headquarter Delaware, United States
- FIGI BBG00MJ3BKW2
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.04
Relación precio/flujo de caja
-486.76
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3156 | ARTV Artiva Biotherapeutics, Inc. - Common Stock | 6.79 USD | -2.16% | -3.14% | -33.50% | +63.22% | 331.96 M USD | ||
| 3180 | OCGN Ocugen, Inc. - Common Stock | 0.94 USD | -2.08% | -8.74% | -9.62% | -45.03% | 318.76 M USD | ||
| 3214 | AGMB AgomAb Therapeutics NV - ADRs representing one | 9.21 USD | +1.43% | +8.23% | -30.23% | -37.35% | 314.68 M USD | ||
| 3215 | PRLD Prelude Therapeutics Incorporated - Common Stock | 3.82 USD | -1.80% | +2.14% | -16.96% | +205.60% | 304.85 M USD |